Barinthus Biotherapeutics plc Investor Relations Material
Latest events
Status Update
Barinthus Biotherapeutics plc
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Barinthus Biotherapeutics plc
Access all reports
Barinthus Biotherapeutics plc is a biotechnology company focused on the development of novel immunotherapies for infectious diseases and cancer. The company specializes in T-cell activating therapeutics and next-generation vaccine platforms designed to enhance immune response. The company is headquartered in London, United Kingdom, and its shares are listed on the NASDAQ.
Key slides for Barinthus Biotherapeutics plc
Corporate Presentation
Barinthus Biotherapeutics plc
Corporate Presentation
Barinthus Biotherapeutics plc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
BRNS
Country
🇺🇸 United States